Loading…
Based on limited metadata, this FDA Warning Letter was issued to Vanda Pharmaceuticals, a pharmaceutical company, on October 22, 2018, regarding drug products. Without access to the full letter text or subject line details, the specific nature of the violations cannot be determined from the available information. The warning was issued under FDA's drug regulatory authority, though the specific issuing office is not identified in the metadata provided.